挑战美敦力！波士顿科学再下一城

医疗器械商业评论01-13

来源：医疗器械商业评论2026年1月12日，波士顿科学公司宣布达成最终协议，将以未披露价格收购植入式胫神经刺激（ITNS）领域创新企业Valencia Technologies。此次收购是波士顿科学继2024年37亿美元收购Axonics后泌尿外科领域的又一重大战略举措。01核心产品eCoin：重新定义尿失禁治疗Valencia的核心产品eCoin是全球首个获FDA批准的植入式胫神经刺激器，其...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2603659270?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-13 13:53","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2603659270","market":"us","top_or_hot":-1,"title":"挑战美敦力！波士顿科学再下一城","media":"医疗器械商业评论","content":"<div>\n<p>来源：医疗器械商业评论2026年1月12日，波士顿科学公司宣布达成最终协议，将以未披露价格收购植入式胫神经刺激（ITNS）领域创新企业Valencia Technologies。此次收购是波士顿科学继2024年37亿美元收购Axonics后泌尿外科领域的又一重大战略举措。01核心产品eCoin：重新定义尿失禁治疗Valencia的核心产品eCoin是全球首个获FDA批准的植入式胫神经刺激器，其...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011314164997a19086&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>挑战美敦力！波士顿科学再下一城</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n挑战美敦力！波士顿科学再下一城\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-13 13:53 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011314164997a19086&s=b><strong>医疗器械商业评论</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>来源：医疗器械商业评论2026年1月12日，波士顿科学公司宣布达成最终协议，将以未披露价格收购植入式胫神经刺激（ITNS）领域创新企业Valencia Technologies。此次收购是波士顿科学继2024年37亿美元收购Axonics后泌尿外科领域的又一重大战略举措。01核心产品eCoin：重新定义尿失禁治疗Valencia的核心产品eCoin是全球首个获FDA批准的植入式胫神经刺激器，其...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011314164997a19086&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1244550221.USD","symbol_name":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011314164997a19086&s=b","article_id":"2603659270","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011314164997a19086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2603659270","pubTimestamp":1768283612,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"来源：医疗器械商业评论2026年1月12日，波士顿科学公司宣布达成最终协议，将以未披露价格收购植入式胫神经刺激领域创新企业Valencia Technologies。此次收购是波士顿科学继2024年37亿美元收购Axonics后泌尿外科领域的又一重大战略举措。此次收购将进一步强化波士顿科学在泌尿外科的领导地位。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","LU0238689110.USD":"贝莱德环球动力股票基金","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU0976567544.SGD":"FTIF - Templeton Global Income A Mdis SGD-H1","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","IE00B3PB1722.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) INC","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","LU0823417653.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","IE00BDGV0183.EUR":"GUINNESS GLOBAL EQUITY INCOME \"C\" (EUR) INC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","IE00BQXX3D17.EUR":"GUINNESS GLOBAL INNOVATORS \"C\" (EUR) ACC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","MDT":"美敦力","LU0345769128.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) ACC","BSX":"波士顿科学","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","LU1116320901.HKD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (HKD) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","LU0225283273.USD":"SCHRODER ISF GLOBAL EQUITY ALPHA \"A\" (USD) ACC","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU2506951875.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) ACC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","BK4082":"医疗保健设备","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","IE00BVYPNW00.USD":"GUINNESS GLOBAL EQUITY INCOME \"C\" (USD) ACC","LU2244417387.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) ACC","SG9999001176.USD":"United Global Healthcare Acc USD","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU0353189680.USD":"富国美国全盘成长基金Cl A Acc","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU0950375773.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC A","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","LU0265550359.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A2\" (USD) ACC","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","LU2028103732.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AMG\" (USD) INC","LU0158827781.USD":" ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (USD) ACC","LU2506952170.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) INC","IE00BGHQF631.EUR":"GUINNESS GLOBAL EQUITY INCOME \"C\" (EUR) ACC"},"translate_title":"Challenge Medtronic! Boston Scientific takes another win","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSX":1.5,"MDT":1.5},"content_text":"来源：医疗器械商业评论2026年1月12日，波士顿科学公司宣布达成最终协议，将以未披露价格收购植入式胫神经刺激（ITNS）领域创新企业Valencia Technologies。此次收购是波士顿科学继2024年37亿美元收购Axonics后泌尿外科领域的又一重大战略举措。01核心产品eCoin：重新定义尿失禁治疗Valencia的核心产品eCoin是全球首个获FDA批准的植入式胫神经刺激器，其革命性设计突破了传统治疗局限：微型化设计：硬币大小（直径25mm），仅需门诊局麻手术植入，植入后外观隐蔽智能无导线技术：内置电池与芯片，通过穹顶状刺激场持续稳定释放胫神经刺激，避免传统骶骨神经刺激器的导线并发症临床验证：关键试验显示68%患者尿急尿失禁发作减少≥50%，长期安全性获证实差异化优势：相比骶骨神经刺激器，eCoin手术创伤小、并发症率低、患者接受度高，已上市多年积累丰富临床经验eCoin系统02市场格局与战略价值美国约3000万40岁以上膀胱过度活动症（OAB）患者长期面临治疗困境。传统骶骨神经刺激虽有效，但因手术复杂、侵入性强、并发症风险高，很少患者愿意接受该疗法。eCoin的出现开创了更安全便捷的ITNS治疗新赛道，其临床优势已获验证。波士顿科学通过本次收购实现以下战略突破：快速切入高速增长的ITNS市场，与现有Axonics产品线形成互补构建全病程解决方案，覆盖从保守疗法到神经调节的全治疗周期抢占市场先机，应对美敦力等竞争对手的布局压力03财务影响与未来展望交易预计2026年上半年完成，对当年调整后每股收益影响中性，GAAP准则下稀释效应可控。波士顿科学泌尿事业部总裁Meghan Scanlon表示：\"eCoin的加入将推动我们拓展至ITNS这一高增长领域，其技术与我们现有盆底健康产品线形成协同效应，最终为患者提供更全面的全病程治疗方案。\"膀胱过度活动症（OAB）对患者生活质量影响深远，涉及心理健康、睡眠、工作效率等多维度。传统治疗手段存在疗效局限或侵入性过高问题，而神经刺激疗法正成为新兴主流方向。此次收购将进一步强化波士顿科学在泌尿外科的领导地位。本文内容仅供参考，不构成投资建议，望读者有效甄别。如有平台转载本篇文章，须自行对该篇文章负责，医疗器械商业评论不对转载引起的二次传播影响负责。*广告推荐阅读HOT年底限时特惠269元！点击图片 直达购买如果您觉得内容有所收获，欢迎星标、点赞、转发！您的支持是我们最大的动力点分享点收藏点在看点点赞","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603659270","isCrawlerRequest":true}